Publication | Closed Access

A Phase II Trial of High-Dose Mitoxantrone, Carboplatin, and Cyclophosphamide with Autologous Bone Marrow Rescue for Recurrent Epithelial Ovarian Carcinoma: Analysis of Risk Factors for Clinical Outcome

Phase Ii TrialMedicineCancer ManagementGynecologyHigh-dose MitoxantroneCancer TreatmentOncologyRadiation OncologyRisk FactorsGynecology OncologyOvarian CancerHealth Sciences